Clinical Trials List
Protocol NumberCLNP023F12301
Active
2021-07-15 - 2026-12-31
Phase III
Not yet recruiting1
Recruiting1
ICD-10D59.3
Hemolytic-uremic syndrome
ICD-9283.11
Non-autoimmune hemolytic anemias, Hemolytic-uremic syndrome
-
Trial Applicant
NOVARTIS (TAIWAN) CO., LTD.
-
Sponsor
-
Trial scale
Multi-Regional Multi-Center
-
Update
2026/02/01
Investigators and Locations
Co-Principal Investigator
The Actual Total Number of Participants Enrolled
0 Recruiting
Co-Principal Investigator
- 謝明翰 無
- Ping-Chin Lai 無
- 陳怡儒 無
The Actual Total Number of Participants Enrolled
0 Not yet recruiting
Condition/Disease
Objectives
Test Drug
Active Ingredient
Dosage Form
Dosage
Endpoints
Inclution Criteria
The Estimated Number of Participants
-
Taiwan
18 participants
-
Global
50 participants
